Chemical terrorism attacks: update on antidotes.
There is well-founded concern that a chemical or radioactive agent will at some point be used as a weapon of terror. There are several antidotes that, if used correctly in a timely fashion, can help lessen the harm caused by these agents. This article is meant to introduce the clinician to several such agents, along with the antidotes useful in the management of exposure to these. It covers the indications, administration, and precautions for using these antidotes.
Lawrence
David T
DT
Blue Ridge Poison Center, Division of Medical Toxicology, Department of Emergency Medicine, University of Virginia, Charlottesville, VA 22908-0774, USA. dtl4n@virginia.edu
Kirk
Mark A
MA
D000931:Antidotes / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D051337:Chemical Terrorism; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D011193:Potassium Iodide / Q000627:therapeutic use*; D011220:Pralidoxime Compounds / Q000627:therapeutic use*; D011832:Radiation Injuries / Q000188:drug therapy*
D000931:Antidotes; D018727:Muscarinic Antagonists; D011220:Pralidoxime Compounds; D011193:Potassium Iodide; D001285:Atropine; D001905:Botulinum Toxins; C028797:pralidoxime